Histologic comparison of hereditary nonpolyposis colorectal cancer associated with MSH2 and MLH1 and colorectal cancer from the general population

被引:34
|
作者
Shashidharan, M
Smyrk, T
Lin, KM
Ternent, CA
Thorson, AG
Blatchford, GJ
Christensen, MA
Lynch, HT
机构
[1] Creighton Univ, Med Ctr, Sect Colon & Rectal Surg, Omaha, NE 68131 USA
[2] Bishop Clarkson Mem Hosp, Dept Pathol, Omaha, NE USA
[3] Creighton Univ, Dept Prevent Med & Publ Hlth, Omaha, NE 68131 USA
[4] Creighton Univ, Hereditary Canc Inst, Omaha, NE 68131 USA
关键词
HNPCC; MSH2; MLH1; Crohn's-like lymphoid reaction;
D O I
10.1007/BF02236925
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PURPOSE: Hereditary nonpolyposis colorectal cancer is reported to have special histologic features. This study com pares the histologic features of hereditary nonpolyposis colorectal cancer to colorectal cancers from the general population when hereditary nonpolyposis colorectal cancer cases are restricted to families with known MSH2 and MLH1 mutations. METHODS: Thirty-seven cancers from kindreds carrying MSH2, mutations, 27 cancers from kindreds carrying MLH1 mutations, and 37 colorectal cancers from the general population were reviewed by a pathologist blinded to hereditary nonpolyposis colorectal cancer gene status. Tumor grade, growth pattern, Crohn's-like lymphoid reaction, mucin production, extent of disease in the bowel wall, and lymph node status were evaluated. RESULTS: Poor differentiation and Crohns-like reaction were a feature of 44 and 49 percent of hereditary nonpolyposis colorectal cancer compared with 14 percent (P = 0.002) and 27 percent (P = 0.049) of colorectal cancers from the general population, respectively. There was no difference in growth pattern, mucin production, lymph node involvement, or local extent of disease between hereditary nonpolyposis colorectal cancer and colorectal cancers from the general population. Poor differentiation and lymph node metastases were found in 57 and 49 percent of MSH2 compared with 26 percent (P = 0.002) and 10 percent (P = 0.03) of MLH1-associated cancers, respectively. There was no difference in growth pattern, mucin production, Crohn's-like lymphoid reaction, or local extent of disease between subgroups of hereditary nonpolyposis colorectal cancer. CONCLUSIONS: Poor differentiation and Crohn's-Like reaction are more common in hereditary nonpolyposis colorectal cancer than colorectal cancers from general population. Poor differentiation and lymph node metastases are more commonly seen in MSH2-associated cancers than MLH1. Evaluation of the natural history, pathogenesis, and prognosis of colorectal cancer in hereditary nonpolyposis colorectal cancer should include consideration of which mismatch repair genes are mutated and what the specific mutations are.
引用
收藏
页码:722 / 726
页数:5
相关论文
共 50 条
  • [21] MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer
    Charbonnier, F
    Olschwang, S
    Wang, Q
    Boisson, C
    Martin, C
    Buisine, MP
    Puisieux, A
    Frebourg, T
    CANCER RESEARCH, 2002, 62 (03) : 848 - 853
  • [22] Deletions account for 17% of pathogenic germline alterations in MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families
    Grabowski, M
    Muller-Koch, Y
    Grasbon-Frodl, E
    Koehler, U
    Keller, G
    Vogelsang, H
    Dietmaier, W
    Kopp, R
    Siebers, U
    Schmitt, W
    Neitzel, B
    Gruber, M
    Doerner, C
    Kerker, B
    Ruemmele, P
    Henke, G
    Holinski-Feder, E
    GENETIC TESTING, 2005, 9 (02): : 138 - 146
  • [23] Genomic rearrangements in MSH2 and MLH1 are rare mutational events in Spanish hereditary nonpolyposis colorectal cancer patients.
    Castellví-Bel, S
    Piñol, V
    Milà, M
    Piqué, JM
    Castells, A
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 231 - 231
  • [24] Novel and recurrent germline alterations in the MLH1 and MSH2 genes identified in hereditary nonpolyposis colorectal cancer patients in Slovakia
    Zavodna, K.
    Bujalkova, M.
    Krivulcik, T.
    Alemayehu, A.
    Skorvaga, M.
    Marra, G.
    Fridrichova, I.
    Jiricny, J.
    Bartosova, Z.
    NEOPLASMA, 2006, 53 (04) : 269 - 276
  • [25] Incidence of hereditary nonpolyposis colorectal carcinoma-related cancer in clinically ascertained MLH1, MSH2 and MSH6 families
    Ramsoekh, D.
    van Leerdam, M. E.
    Wagner, A.
    Dooijes, D.
    Tops, C.
    Kuipers, E. J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (07) : A26 - A27
  • [26] Association of MLH1 and MSH2 promoter polymorphisms and colorectal cancer
    Mrkonjic, Miralem
    Raptis, Stavroula R.
    Pethe, Vaiju
    Knight, Julia
    Monga, Neerav
    Daftary, Darshana
    Younghusband, Ban
    Parfrey, Patrick
    Gallinger, Steve
    Green, Roger
    McLaughlin, John
    Bapat, Bharati
    CANCER RESEARCH, 2006, 66 (08)
  • [27] MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers:: A study of hereditary nonpolyposis colorectal cancer families
    Vasen, HFA
    Stormorken, A
    Menko, FH
    Nagengast, FM
    Kleibeuker, JH
    Griffioen, G
    Taal, BG
    Moller, P
    Wijnen, JT
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (20) : 4074 - 4080
  • [28] DNA Methylation Identifies Loci Distinguishing Hereditary Nonpolyposis Colorectal Cancer Without Germ-Line MLH1/MSH2 Mutation from Sporadic Colorectal Cancer
    Chen, Chung-Hsing
    Jiang, Shih Sheng
    Hsieh, Ling-Ling
    Tang, Reiping
    Hsiung, Chao A.
    Tsai, Hui-Ju
    Chang, I-Shou
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2016, 7
  • [29] MLH1 and MSH2 mutations in Colombian families with hereditary nonpolyposis colorectal cancer (Lynch syndrome) -: description of four novel mutations
    Giraldo, A
    Gómez, A
    Salguero, G
    García, H
    Aristizábal, F
    Gutiérrez, O
    Angel, LA
    Padrón, J
    Martínez, C
    Martínez, H
    Malaver, O
    Flórez, L
    Barvo, R
    FAMILIAL CANCER, 2005, 4 (04) : 285 - 290
  • [30] MLH1 and MSH2 Mutations in Colombian Families with Hereditary Nonpolyposis Colorectal Cancer (Lynch syndrome) – Description of Four Novel Mutations
    Alejandro Giraldo
    Andrea Gómez
    Gustavo Salguero
    Herbert García
    Fabio Aristizábal
    Óscar Gutiérrez
    Luis Alberto Ángel
    Jorge Padrón
    Carlos Martínez
    Humberto Martínez
    Omar Malaver
    Luis Flórez
    Rosa Barvo
    Familial Cancer, 2005, 4 : 285 - 290